| Date | Form | Description | Docs | XBRL | Pages |
| 10/10/12 | 8-K | Current report filing |
|
20 | |
| 10/10/12 | 8-K | Current report filing |
|
3 | |
| 10/02/12 | 3 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/28/12 | 3 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/25/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/25/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/24/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/24/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/24/12 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
10 | |
| 09/24/12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
6 |
Latest News & Events
Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
Read More...Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic
Read More...